← Open Payments lookup

NPI 1306487855: Open Payments

NPI 1306487855. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$464 in 31 payments from 9 companies in 2025. Trend: 2023 $2,601 · 2024 $2,216 · 2025 $464

Food & beverage: $454Education: $10
CompanyPaymentsAmount
Janssen Biotech, Inc.16$134
ABBVIE INC.6$127
Takeda Pharmaceuticals U.S.A., Inc.3$71
Regeneron Healthcare Solutions, Inc.1$37
Braintree Laboratories, Inc.1$24
Aimmune Therapeutics, Inc.1$23
Lilly USA, LLC1$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$17
Janssen Pharmaceuticals, Inc1$10

Products named: TREMFYA, RINVOQ, EOHILIA, LINZESS, DUPIXENT, ENTYVIO, SUFLAVE, VOWST.